Storr J, Barrell E, Barry W, Lenney W, Hatcher G
Lancet. 1987 Apr 18;1(8538):879-82. doi: 10.1016/s0140-6736(87)92857-1.
140 children of 184 with acute asthma entered a randomised double-blind trial of oral prednisolone (n = 67) compared with placebo (n = 73) administered soon after admission. The dose of prednisolone was 30 mg in children under 5, otherwise 60 mg. All children also received salbutamol. All had moderate or severe dyspnoea. Initial evaluation was similar for both groups. On reassessment after a few hours 20 children in the prednisolone group were fit for discharge compared with only 2 in the placebo group. There were no early reattendances. Children remaining in hospital had a shorter median duration of stay and were less likely to require further steroid therapy if they had initially received prednisolone. In acute asthma the prompt use of a single dose of oral prednisolone can reduce morbidity and the need for hospital care.
184名患有急性哮喘的儿童中,140名进入了一项口服泼尼松龙的随机双盲试验(n = 67),与入院后不久给予的安慰剂(n = 73)进行比较。5岁以下儿童泼尼松龙的剂量为30毫克,其他情况为60毫克。所有儿童还接受了沙丁胺醇治疗。所有儿童均有中度或重度呼吸困难。两组的初始评估相似。几小时后重新评估时,泼尼松龙组有20名儿童适合出院,而安慰剂组只有2名。没有早期复诊情况。如果最初接受了泼尼松龙治疗,留在医院的儿童中位住院时间较短,且不太可能需要进一步的类固醇治疗。在急性哮喘中,迅速使用单剂量口服泼尼松龙可降低发病率和住院需求。